Parallax Volatility Advisers, L.P. Intercept Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $137,266 - $237,833	-10,955 Reduced 97.55%	275 $3,000
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $122,601 - $170,121	-10,560 Reduced 48.46%	11,230 $138,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $266,055 - $429,263	21,790 New	21,790 $304,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $228 - $312	-16 Reduced 0.01%	125,000 $2.04 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $648,499 - $1.02 Million	49,923 Added 66.48%	125,016 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $379,280 - $601,058	24,533 Added 48.52%	75,093 $1.5 Million
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $1,507 - $2,944	-78 Reduced 0.15%	50,560 $1.17 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $1.24 Million - $2.15 Million	50,638 New	50,638 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $408,081 - $707,974	-16,670 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $64,967 - $88,817	1,662 Added 11.07%	16,670 $691,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $237,703 - $468,483	5,090 Added 51.32%	15,008 $719,000
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $471,654 - $1.16 Million	9,755 Added 5984.66%	9,918 $624,000
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $317,659 - $687,265	-5,538 Reduced 97.14%	163 $20,000
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $123,777 - $169,690	2,109 Added 58.71%	5,701 $378,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $128,709 - $199,725	1,655 Added 85.44%	3,592 $286,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $101,655 - $133,592	1,107 Added 133.37%	1,937 $217,000
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $55,677 - $82,072	649 Added 358.56%	830 $84,000
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $10,860 - $15,506	181 New	181 $15,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $117,723 - $150,169	-2,233 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $129,960 - $162,473	2,233	2,233 $130,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account